Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2010
11/03/2010CN1310715B Polymorph of medicine
11/03/2010CN101878209A Oxypiperidine derivatives and methods of use thereof
11/03/2010CN101878205A Phenyl-oxetanyl-derivatives
11/03/2010CN101878030A Compositions and methods for treating immunological and inflammatory diseases and disorders
11/03/2010CN101875920A DcR3 (Decoy Receptor 3) and GAD65 (Glutamic Acid Decarboxylase 65) double gene co-expression recombinant adenovirus as well as preparation method and application thereof
11/03/2010CN101875897A Six-herbs refined wine
11/03/2010CN101875694A Antibody of TNF (Tumor Necrosis Factor) alpha and application thereof
11/03/2010CN101874897A Immunomodifier for reducing blood total cholesterol and administration method thereof
11/03/2010CN101874893A Health-care medicinal liquor
11/03/2010CN101874854A Traditional Chinese medicine composition for tonifying middle-Jiao and Qi and protecting liver for pets and preparation method thereof
11/03/2010CN101874850A Medicament for treating chronic urticaria
11/03/2010CN101874826A Granulose rabdosia rubescens compound preparation and preparation method thereof
11/03/2010CN101874824A Active extract containing trilobatin and application thereof
11/03/2010CN101874820A Compound preparation for treating systemic lupus erythematosus
11/03/2010CN101874816A Tripterygium hypoglaucum film coated tablets and preparation method thereof
11/03/2010CN101874815A Compound nutritional tricholoma matsutake capsule
11/03/2010CN101874779A Fructose diphosphate sodium liposome solid preparation and novel application thereof
11/03/2010CN101874627A Pearl powder health-care food for enhancing immunity
11/03/2010CN101361703B Sirolimos sustained and controlled release preparation and preparation method thereof
11/03/2010CN101289517B Process for abstracting momordica grosvenori polysaccharide
11/03/2010CN101181395B Medicine preparations for curing dermatosis and preparation method thereof
11/02/2010US7825260 (R)-2-amino-4-(2-benzo[1,3]dioxol-5-yl-benzoxazol-5-yl)-2-methyl-butan-1-ol; for the treatment or prevention of allo- or xenograft acute or chronic rejection or inflammatory or autoimmune disorders, or as a chemotherapeutic agent, e.g a malignant cell anti-proliferative agent
11/02/2010US7825224 Identifying regulatory compounds which dissociate/destsbilize receptor/ligand binding activity; for use in controlled immune suppression
11/02/2010US7825216 Phenylanine derivatives
11/02/2010US7825157 Methods for improving the aesthetic appearance of skin
11/02/2010US7825146 Sulfonamide derivative having isoxazole ring
11/02/2010US7825140 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
11/02/2010US7825124 Indolylmaleimide derivatives
11/02/2010US7825116 N2, N4-bis-aryl-5-fluoro-2,4-pyrimidinediamines
11/02/2010US7825109 Compound capable of binding S1P receptor and pharmaceutical use thereof
11/02/2010US7824696 Modified nucleotides for immunotherapy; induce immunology response; consisting of nucleoside methylphosphonate and 2'-O-methyl-ribonucleoside groups
11/02/2010US7824695 recombinant proteins comprise cell recognition moiety that binds alpha 2 macroglobulin receptor, and bioactive moiety (pseudomonas exotoxin), which mediates systemic effect, does not function as immunogen and does not have ADP ribosylating activity
11/02/2010US7824683 Methods for augmenting an immune response using anti-CD40 antibodies
11/02/2010CA2621088C Genetically engineered fowlpox-based vaccine strain
11/02/2010CA2462799C Pyrimidine derivatives
11/02/2010CA2439784C Pyrazolopyrimidinone derivatives having pde7 inhibiting action
11/02/2010CA2437715C Carboline derivatives
11/02/2010CA2417432C Modified polypeptides stabilized in a desired conformation and methods for producing same
11/02/2010CA2337422C Preventing airway mucus production by administration of egf-r antagonists
11/02/2010CA2311456C Imidazonaphthyridines and their use in inducing cytokine biosynthesis
10/2010
10/28/2010WO2010124058A1 Compositions for use in the treatment of chronic obstructive pulmonary diseases and asthma
10/28/2010WO2010123971A2 Hydrogels for combinatorial delivery of immune-modulating biomolecules
10/28/2010WO2010123931A1 Methods of treatment for solid tumors
10/28/2010WO2010123919A2 Piperidine inhibitors of janus kinase 3
10/28/2010WO2010123243A2 Composition containing a testis extract for treating or preventing diseases
10/28/2010WO2010123069A1 Method for diagnosing autoimmune disease patient, in vitro diagnostic agent and therapeutic agent therefor
10/28/2010WO2010123037A1 Agent for regulating composition ratio of intestinal bacterial flora
10/28/2010WO2010123012A1 Antibody containing igg2 having amino acid mutation introduced therein
10/28/2010WO2010122945A1 Method for preparing human t cell population having both cytotoxic and immunosuppressive activities
10/28/2010WO2010122294A1 Thiophene inhibitors of ikk-b serine-threonine protein kinase
10/28/2010WO2010122069A1 5-alkynyl-pyridines
10/28/2010WO2010121503A1 Tacrolimus injection preparation
10/28/2010WO2010080577A3 Oxepine modulators of h1 receptors and/or inhibitors of mast cell degranulation
10/28/2010WO2010018378A8 Vaccine comprising amb a 1 peptides for use in the treatment of ragweed allergy
10/28/2010WO2009140089A8 Sulfone compounds which modulate the cb2 receptor
10/28/2010WO2009135615A8 Means for the treatment and/or prophylaxis of an autoimmune disease and for the formation of regulatory t-cells
10/28/2010WO2009114814A3 Therapeutic substances that modulate genome methylation
10/28/2010US20100273872 Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders
10/28/2010US20100273862 Phosphatases which activate map kinase pathways
10/28/2010US20100273853 Novel isoindol derivatives as ep4 receptor agonists
10/28/2010US20100273850 4-heteroaryl-substituted phenoxyphenylacetic acid derivatives
10/28/2010US20100273849 Metalloproteinase Inhibitors
10/28/2010US20100273833 2-sulfinyl- and 2-sulfonyl-substituted imidazole derivatives and their use as cytokine inhibitors
10/28/2010US20100273831 Fluoro alkyl substituted benzimidazole cannabinoid agonists
10/28/2010US20100273824 Substituted 1,3-dioxanes and their uses
10/28/2010US20100273806 Tetrahydrocyclopenta[b]indol-3-yl carboxylic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
10/28/2010US20100273797 Alpha-ketoamides and derivatives thereof
10/28/2010US20100273795 Arylsulfonamide ccr3 antagonists
10/28/2010US20100273785 2,5-disubstituted arylsulfonamide ccr3 antagonists
10/28/2010US20100273774 Indolymaleimide derivatives
10/28/2010US20100273771 Oxadiazole derivatives active on sphingosine-1-phosphate (sip)
10/28/2010US20100273768 Inhibitors of Bruton's Tyrosine Kinase
10/28/2010US20100273757 Pyrazine derivatives useful as adenosine receptor antagonists
10/28/2010US20100273751 Substituted benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses
10/28/2010US20100273728 Formulations For The Oral Administration of Therapeutic Agents and Related Methods
10/28/2010US20100273723 Peptides of il-2
10/28/2010US20100273705 Method for inhibiting "Melanoma Inhibitory Activity" MIA
10/28/2010US20100273701 Use of salusin beta alone or in combination with octreotide as a therapeutic agent
10/28/2010US20100273700 Use of a peptide as a therapeutic agent
10/28/2010US20100272823 Pulmonary delivery particles comprising water insoluble or crystalline active agents
10/28/2010US20100272788 Vaccines for malaria
10/28/2010US20100272786 Vaccine
10/28/2010US20100272785 Rna sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles
10/28/2010US20100272771 Device including bone cage and method for treatment of disease in a subject
10/28/2010US20100272756 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
10/28/2010US20100272752 Vaccine for viruses that cause persistent or latent infections
10/28/2010US20100272751 Truncated l1 protein of human papillomavirus type 18
10/28/2010US20100272749 Optimized expression of HPV 58 L1 in yeast
10/28/2010US20100272747 Polyvalent chimeric rubella virus-based vaccines
10/28/2010US20100272743 Staphylococcus epidermidis nucleic acids and proteins
10/28/2010US20100272742 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
10/28/2010US20100272738 Anti-ox40l antibodies and methods using same
10/28/2010US20100272735 METHOD TO TREAT USING ANTAGONISTIC ANTI-hTNFSF13B HUMAN ANTIBODIES
10/28/2010US20100272729 Mammalian tumor susceptibility gene products and their uses
10/28/2010US20100272728 Mammalian tumor susceptibility gene products and their uses
10/28/2010US20100272727 Compound for controlling appetite
10/28/2010US20100272726 Assays, methods and means
10/28/2010US20100272723 Optimized Antibodies that Target CD19
10/28/2010US20100272718 Antibodies Against Human NKG2D and Uses Thereof
10/28/2010US20100272716 Antibodies to VLA-1
1 ... 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 ... 1172